What's so great
When the results of a clinical trial, demonstrating Pradaxa's superiority to warfarin, broke midway through a presentation at a major medical meeting in Barcelona, 4,000 cardiologists leapt to their feet and applauded. Among the delegates was Boehringer Ingelheim president and CEO Greg Behar.
"It was just a fantastic,
Greg Behar, President and CEO, Boehringer Ingelheim
CLICK HERE to find out why Medical Marketing & Media's editors named Boehringer Ingelheim their All-Star Company of the Year.
- Exclusive interviews with Greg Behar, president and CEO; David Pass, VP, US pipeline marketing; and Kathleen Dowd, VP, respiratory marketing
- Financial performance highlights
- 2011 sales data for BI's top products
- Marketing spend for 10 brands, broken out by consumer and HCP
- Examples of marketing initiatives
Read the story; share it instantly on Facebook, Twitter, Google+ and Linkedin; post your own comments; and view or download a PDF of the beautifully photographed and designed original layout from the print edition of MM&M. It's all FREE and just one click away.